Plasma kinetics and urinary excretion of primaquine in man. 1980

J Greaves, and D A Evans, and H M Gilles, and K A Fletcher, and D Bunnag, and T Harinasuta

1 The kinetics of primaquine have been studied in twenty volunteers after single and multiple dose regimes. 2 The kinetic parameters were similar in glucose-6-phosphate dehydrogenase (G6PD) normal Thais, G6PD deficient Thais and in Caucasians. 3 The Caucasian subjects showed about 1% of the dose was excreted in the urine. 4 The kinetic parameters obtained from multiple dose studies in Thais were very similar to those obtained from single dose studies in Thais.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011319 Primaquine An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404) Primacin,Primaquine Diphosphate,Primaquine Phosphate,Diphosphate, Primaquine,Phosphate, Primaquine
D005953 Glycogen Storage Disease Type I An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood. Glucose-6-Phosphatase Deficiency,Glucosephosphatase Deficiency,Glycogenosis 1,Hepatorenal Glycogen Storage Disease,von Gierke Disease,Deficiency, Glucosephosphatase,Gierke Disease,Gierke's Disease,Glycogen Storage Disease 1 (GSD I),von Gierke's Disease,Deficiencies, Glucose-6-Phosphatase,Deficiencies, Glucosephosphatase,Deficiency, Glucose-6-Phosphatase,Disease, Gierke,Disease, Gierke's,Disease, von Gierke,Disease, von Gierke's,Gierkes Disease,Glucose 6 Phosphatase Deficiency,Glucose-6-Phosphatase Deficiencies,Glucosephosphatase Deficiencies,von Gierkes Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D044465 White People Persons having origins in any of the white racial groups of Europe, the Middle East, or North Africa. Note that OMB category WHITE is available for the United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. European Continental Ancestry Group,White Person,Caucasian Race,Caucasoid Race,Caucasian Races,Caucasoid Races,People, White,Person, White,Race, Caucasian,Race, Caucasoid,White Peoples,White Persons
D044466 Asian People Persons having origins in any of the Asian racial groups of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. Note that OMB category ASIAN is available for United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. Asian Continental Ancestry Group,Asian Person,Asiatic Race,Mongoloid Race,Asian Peoples,Asian Persons,Asiatic Races,Mongoloid Races,People, Asian,Person, Asian,Race, Asiatic,Race, Mongoloid

Related Publications

J Greaves, and D A Evans, and H M Gilles, and K A Fletcher, and D Bunnag, and T Harinasuta
January 1979, The American journal of physiology,
J Greaves, and D A Evans, and H M Gilles, and K A Fletcher, and D Bunnag, and T Harinasuta
October 1965, The Journal of pharmacy and pharmacology,
J Greaves, and D A Evans, and H M Gilles, and K A Fletcher, and D Bunnag, and T Harinasuta
December 1981, Toxicology letters,
J Greaves, and D A Evans, and H M Gilles, and K A Fletcher, and D Bunnag, and T Harinasuta
April 1973, Circulation,
J Greaves, and D A Evans, and H M Gilles, and K A Fletcher, and D Bunnag, and T Harinasuta
April 1981, Journal of clinical pathology,
J Greaves, and D A Evans, and H M Gilles, and K A Fletcher, and D Bunnag, and T Harinasuta
January 1976, Cancer treatment reports,
J Greaves, and D A Evans, and H M Gilles, and K A Fletcher, and D Bunnag, and T Harinasuta
January 1989, European journal of clinical pharmacology,
J Greaves, and D A Evans, and H M Gilles, and K A Fletcher, and D Bunnag, and T Harinasuta
January 1975, Annales pharmaceutiques francaises,
J Greaves, and D A Evans, and H M Gilles, and K A Fletcher, and D Bunnag, and T Harinasuta
January 1989, European journal of clinical pharmacology,
J Greaves, and D A Evans, and H M Gilles, and K A Fletcher, and D Bunnag, and T Harinasuta
January 1980, European journal of drug metabolism and pharmacokinetics,
Copied contents to your clipboard!